High-Dose Melphalan and a Second Stem Cell Transplant or Low-Dose Cyclophosphamide in Treating Patients With Relapsed Multiple Myeloma After Chemotherapy

NCT00747877 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

460

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma and Plasma Cell Neoplasm

Interventions

DRUG: cyclophosphamide
DRUG: melphalan
PROCEDURE: autologous hematopoietic stem cell transplantation

Sponsor

Leeds Cancer Centre at St. James's University Hospital